FORT WORTH, Texas -- Healthpoint Ltd., a DFB
Pharmaceuticals affiliate company, will air its first live continuing
education Webcast, "Management of Lower Extremity Wounds Complicated by Acute
Arterial Insufficiency and Ischemia," on Tuesday, December 2, 2003 from 7 p.m. to
8:30 p.m. EST. It will be re-broadcast December 3 and 4 from 8 p.m. to 9:30 p.m.
EST.
The complimentary program, part of a continuing series supported by
educational grants from Healthpoint, provides timely access to the latest
advances in wound care and treatment modalities.
Physicians who complete the course will receive one CME hour.
Pharmacists, nurses, and podiatrists will receive one contact hour. Register
by visiting http://woundsresearch.com/wnds/webcast/mlew/reg.cfm .
Jeffrey Niezgoda, MD, of the Center for Comprehensive Wound Care and
Hyperbaric Oxygen Therapy, and Mark W. Mewissen, MD, director of peripheral
vascular services at Wisconsin Heart and Vascular Clinics, both in Milwaukee,
have developed a comprehensive program that discusses potential interventions,
treatment protocols, and the products available for use with patients with
proven peripheral vascular disease (PVD).
The program's objectives are to:
1. Describe non-invasive testing, such as ankle brachial index (ABI),
transcutaneous oximetry mapping (TCOM), and color Doppler flow
imaging, in the evaluation and diagnosis of patients with wounds due
to peripheral arterial disease (PAD).
2. Discuss the role of the vascular laboratory in the diagnosis of
peripheral arterial disease, in the appropriate selection of patients
for angiographic evaluation of the lower extremity, and in the non-
invasive surveillance in patients who have undergone lower limb
revascularization.
3. Define Hyperbaric Oxygen Therapy (HBOT) and the indications for use
in the management algorithm for patients with ischemic wounds.
4. Describe improved outcomes seen in patients with ischemic wounds that
are managed with a comprehensive approach integrating wound care and
hyperbaric, with vascular-endovascular medicine, and vascular
surgery.
5. Illustrate concepts with outcome data and case studies.
The program will be archived for one year on the WOUNDS, Podiatry Today,
ECPN, OWM and Healthpoint Web sites. This activity is sponsored by HMP
Communications, accredited by the Accreditation Council for Continuing Medical
Education and has been planned and produced in accordance with the ACCME
Essential Areas and Policies. For additional information, call HMP at
(800) 237-7285.
Source: Healthpoint, Ltd.
Hiding in Plain Sight: The Most Harmful and Costly Hospital-Acquired Infection
February 5th 2025Nonventilator hospital-acquired pneumonia (NV-HAP) is a deadly, overlooked infection impacting patient outcomes. With new diagnostic tools and prevention strategies, hospitals must prioritize oral hygiene to reduce risk.
The Hidden Dangers of Hospital Ventilation: Are We Spreading Viruses Further?
January 31st 2025New research reveals hospital ventilation and air purifiers may unintentionally spread viral particles, increasing infection risks. Infection preventionists must rethink airflow strategies to protect patients and staff.
Alcohol-Based Antiseptics Show Promise for Nasal Decolonization and SSI Prevention
January 23rd 2025A meta-analysis found alcohol-based antiseptics significantly reduce Staphylococcus aureus-related surgical site infections (SSIs), demonstrating efficacy comparable to mupirocin and iodophor, supporting their expanded use in infection prevention strategies.
Top 7 Infection Control Today Articles of 2024: Insights and Innovations
December 30th 2024From advanced sterilization methods to combating antimicrobial resistance, Infection Control Today’s top articles of 2024 delivered actionable strategies for safer healthcare environments and improved patient outcomes.
Understanding NHSN's 2022 Rebaseline Data: Key Updates and Implications for HAI Reporting
December 13th 2024Discover how the NHSN 2022 Rebaseline initiative updates health care-associated infection metrics to align with modern health care trends, enabling improved infection prevention strategies and patient safety outcomes.